New Podcast Episode Highlights Behavioral Health’s Role in Global Health Equity
In the latest episode of Disruptors at Work: An Integrated Care Podcast, special host Ngozika Egbuonu, Doctor of Behavioral Health (DBH) program student at Cummings Graduate Institute for Behavioral Health Studies (CGI) and Director of Programs at the Technology Association of Grantmakers, sits down with Dr. Nnanyelugo Gerald Odezulu, Senior Biocompatibility Specialist at ConMed, for a conversation on advancing global health equity through integrated care. They explore how DBHs can drive change in rural, urban, and lower-income communities by expanding health literacy, strengthening cross-disciplinary collaboration, and transforming care delivery systems. This episode offers practical insights and inspiration for healthcare professionals committed to shaping a more accessible, effective, and equitable future in healthcare.
Thank you to our subject matter experts:
-
-
- Ngozika “Gozi” Egbuonu, MA, MS
- Dr. Nnanyelugo Odezulu, Ph.D
-
About the Subject Matter Experts:
Ngozika “Gozi” Egbuonu, MA, MS

Gozi Egbuonu is the Director of Programs at the Technology Association of Grantmakers (TAG), a nonprofit organization with a mission to cultivate the strategic, equitable, and innovative use of technology in philanthropy. Before TAG, Gozi was an Impact Officer at Network for Good’s (now Bonterra) capacity-building program called Jumpstart. Gozi helped generate more than $500,000 in grant funding to help nonprofits become more sustainable. In addition, Gozi also helped create meaningful content and events to educate philanthropic communities about the power of trust-based partnerships between grantmakers and nonprofits. Committed to using technology to improve lives and advance social change, Gozi is researching the use of medical technology, like AI, to improve healthcare delivery while pursing her doctorate in behavioral health from Cummings Graduate Institute for Behavioral Health Studies.
Dr. Nnanyelugo Odezulu, Ph.D

Dr. Nnanyelugo G. Odezulu is a seasoned regulatory toxicologist and medical device biocompatibility specialist with a robust background in toxicological risk assessment. He currently contributes his expertise to CONMED Corporation, a global medical technology company. Dr. Odezulu earned his Ph.D. from the University of Florida, where he cultivated a deep passion for public health and honed his skills in evaluating the safety and compatibility of medical devices. Beyond his professional endeavors, Dr. Odezulu actively engages with the scientific community through discussions on medical device recalls and advancements in biocompatibility testing. His commitment to public health is evident in his proactive approach to addressing environmental concerns and ensuring the safety of medical products.
